SELEXIPAG | N207947 | ACTELION PHARMACEUTICALS US INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Actelion Pharmaceuticals US, Inc. et al v. Apotex Inc. et al 2 patentsANDA 220457selexipag | D. Del. | 2025-12-10 | Active | — |
ACTELION PHARMACEUTICALS US, INC. et al v. VGYAAN PHARMACEUTICALS LLC et al 1 patentANDA 214055selexipag | D.N.J. | 2025-09-03 | Terminated 2025-12-03 | — |
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al 1 patentANDA 214414selexipag | D. Del. | 2023-04-04 | Terminated 2023-07-05 | — |
ACTELION PHARMACEUTICALS LTD et al v. MSN PHARMACEUTICALS INC. et al 3 patentsANDA 214414, 214367, 214055, 214302selexipag | D.N.J. | 2020-04-09 | Terminated 2022-01-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7205302 | Oct 31, 2026PED: Apr 30, 2027 | PED | Yes | Yes | — | |
| 8791122 | Aug 1, 2030PED: Feb 1, 2031 | PED | Yes | Yes | — | — |
| 9173881 | Aug 12, 2029PED: Feb 12, 2030 | PED | — | — | — | |
| 9284280 | Jun 25, 2030PED: Dec 25, 2030 | PED | — | — | — | |
| 10821108 | Dec 1, 2036PED: Jun 1, 2037 | PED | — | Yes | — | |
| 10828298 | Dec 1, 2036PED: Jun 1, 2037 | PED | — | Yes | — |